rxpertusa logo spacer rxpertusa wings
logo spacer spacer spacer
rxpertusa
spacer home
about us
assessment tools
sample consult
acps services
contact us
favorite links

red line

spacer spacer news

The latest Mainline newsletters for the General Public are listed here.


news

For healthcare professionals we have a Mainline newsletter in a Professional version here.


Printer Friendly

Mainline

Volume 3 August 11, 2006 Number 6

An Exclusive Continuing Education Publication of Acadiana Consultant Pharmacy Service
Author, Publisher, Editor-in Chief, Typesetter & Printer, Charles S. Feucht,PD,FASCP PharmD candidate

Medication News & Updates

      Geriatric diuretic of Choice

       For patients with renal function above 50ml/min thiazides remain the agents of choice. However, for those with CRCl rates lower than this thiazides are ineffective with the exception of metolazone (Zaroxylon) which may still be effective down to 30ml/min.

     The loop diuretics, Torsemide(Demadex), Bumetandie (Bumex), or furosemide (Lasix), should be considered for patients with creatinine clearances below 40-50ml/min. When a loop diuretic is indicated the following considerations should be made. On a weight to weight basis torsemide is twice as potent as furosemide, and provides a longer duration of action at lower urinary concentrations. This allows for a 24-hour dosage interval and avoids the paradoxical antidiuresis seen with furosemide or bumetanide. Torsemide doses of 10-20 mg are roughly equivalent to 40 mg furosemide and 1 mg bumetanide.

      Limited data suggest torsemide exhibits less pronounced effects on the excretion of calcium, magnesium, and potassium than furosemide or bumetanide, and torsemide, has shown minimal effects on sodium and potassium, however,at higher doses the distinctions may be insignificant. Reports of hyperuricemia followed clinical trials with bumetanide (18.4%), ethacrynic acid and furosemide, although exact percentage values are unknown for ethacrynic acid and furosemide. Torsemide again proved superior to these agents with no or slight increases in uric acid levels following administration during clinical trials. Torsemide is effective in the treatment of mild to moderate essential hypertension, and in the reduction of edema associated with congestive heart failure, renal disease and hepatic cirrhosis. Furosemide and bumetanide are not known to be as effective as thiazides or torsemide for blood pressure control.

The chart below shows the some basic pharmacokinetic properties of the loop diuretics for comparison.

 

Furosemide

Bumetanide

Torsemide

Usual daily dose

20-160mg

0.5-4mg

10-80mg

Ceiling dose: 1

     

Normal renal function

80-160mg

0.5-4mg

40mg

CrCl 20-50ml/min

160mg

2mg

40mg

CrCl <20ml/min

400mg

8-10mg

100mg

Bioavailability

10-100%

average 50%

80-90%

80-100%

Affected by food

Yes

Yes

No

Half – life (t ½)

0.3-3.4 hours

0.3-1.5 hours

3-4 hours

                1 Ceiling dose: single dose above which additional response is unlikely to be observed.

 

spacer

rule

Home ] [ About Us  ] [ Assessment Tools  ] [ Sample Consult  ]
Contact Us  ] [ Favorite Links  ]

Copyright © www.rxpertusa.com. Designed by PcHousekeeping.com
  spacer spacer